Market Closed

CADL
Candel Therapeutics
$ 6.20
-26.10%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Candel Therapeutics News

Latest Candel Therapeutics Stock News & CADL Headlines

CADL INVESTIGATION: Candel Therapeutics Investigated for Securities Fraud by Block & Leviton: Investors Should Contact the Firm
2 days ago | globenewswire.com
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
2 days ago | globenewswire.com
Biotech Is Booming; Here Are 4 Names Outperforming Despite This Deep Correction
6 days ago | seekingalpha.com
Candel Therapeutics to Present at November Investor Conferences
19 days ago | globenewswire.com
Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026
2 months ago | globenewswire.com
Candel Therapeutics: Strong Buy On Aglatimagene Prostate Cancer BLA Filing In Q4
2 months ago | seekingalpha.com
4 Prostate Cancer Drug Stocks to Watch During Awareness Month
2 months ago | zacks.com
Candel Therapeutics Appoints Martine Zimmermann, PharmD, to its Board of Directors
2 months ago | globenewswire.com
Candel Therapeutics to Present at September Investor Conferences
3 months ago | globenewswire.com
Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
3 months ago | globenewswire.com
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

CADL
Candel Therapeutics
$ 6.20
-26.10%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago